T. Rowe Price Associates’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $34.4M | Sell |
|
|||||
|
2025
Q2 | $28.5M | Sell |
|
|||||
|
2025
Q1 | $30.8M | Sell |
|
|||||
|
2024
Q4 | $49.4M | Buy |
|
|||||
|
2024
Q3 | $35M | Buy |
|
|||||
|
2024
Q2 | $22.4M | Buy |
|
|||||
|
2024
Q1 | $35.9M | Buy |
|
|||||
|
2023
Q4 | $27.9M | Buy |
|
|||||
|
2023
Q3 | $18.5M | Sell |
|
|||||
|
2023
Q2 | $26.7M | Buy |
|
|||||
|
2023
Q1 | $28.8M | Buy |
|
|||||
|
2022
Q4 | $28M | Sell |
|
|||||
|
2022
Q3 | $30.7M | Sell |
|
|||||
|
2022
Q2 | $50.8M | Sell |
|
|||||
|
2022
Q1 | $75M | Buy |
|
|||||
|
2021
Q4 | $84.7M | Buy |
|
|||||
|
2021
Q3 | $69.3M | Buy |
|
|||||
|
2021
Q2 | $61.3M | Buy |
|